Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Prosthetic heart valves are a device which mimics the function of human heart valves and have a passive mode of functioning; opening and closing of valves are responses to pressure and flow changes within the heart. GlobalData uses proprietary data and analytics to provide a comprehensive report on the prosthetic heart valves devices market, including market shares of different players within Italy. Buy the latest report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Italy Prosthetic Heart Valves Market Share

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

In 2022, GlobalData’s Market Model methodology determined that the leading player in the prosthetic heart valves market in Italy was Edwards Lifesciences followed by Abbott Laboratories, Medtronic, Gyrus Capital, Artivion, Lepu Medical Technology (Beijing) and TTK Healthcare.

Prosthetic Heart Valves are for the patients that have a heart valvular disease where they need their valve to be replaced. Prosthetic heart valve includes both Mechanical Heart Valves and Tissue or Biological Heart Valves. Mechanical heart valves are generally made of non–physiological materials with a mobile occluder, which is made of rigid materials. Tissue heart valve are a combination of tissue and synthetic biomaterials with the tissue itself being flexible.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the prosthetic heart valves devices market within Italy was expected to be over $60m in 2022.

For the latest complete market share analysis of prosthetic heart valves device market in Italy, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.